Specific anti-cd38 antibodies for treating human cancers

作者: Krzysztof J. Grzegorzewski , Blake Tomkinson , Marie-Laure Ozoux , Antoine Deslandes

DOI:

关键词:

摘要: The present disclosure concerns an antibody that specifically binds CD38 which is capable of killing a CD38+ cell by induction apoptosis, antibody-dependent cell- mediated cytotoxicity (ADCC), and complement-dependent cytotoxicity. disclosed may be used as medicament or in the making medicament, wherein to administered human subject safe therapeutic dose about 20 mg/kg below. In one embodiment, for treating multiple Myeloma humans.

参考文章(33)
Thomas G Martin, Stephen A. Strickland, Martha Glenn, Wei Zheng, Nikki Daskalakis, Joseph R. Mikhael, SAR650984, a CD38 Monoclonal Antibody In Patients With Selected CD38+ Hematological Malignancies- Data From a Dose-Escalation Phase I Study Blood. ,vol. 122, pp. 284- 284 ,(2013) , 10.1182/BLOOD.V122.21.284.284
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Michel De Weers, Paul Parren, Steen Lisby, Jan Van De Winkel, Yvo Graus, Ole Baadsgaard, Martine Van Vugt, Judith Oprins, Combination treatment of cd38-expressing tumors ,(2007)
Blake T. Aftab, Blake Tomkinson, Byron C. Hann, Thomas G. Martin, Compositions comprising anti-CD38 antibodies and lenalidomide ,(2013)
Anna Skaletskaya, Viktor S. Golmakher, Peter U Park, Daniel Tavares, Jutta Deckert, Vincent Mikol, Laura M. Bartle, VĂ©ronique Blanc, Novel anti-cd38 antibodies for the treatment of cancer ,(2007)
Gregory Landes, Andrew Walling Drake, Kathleen Ann Elias, Gyorgy Pal Snell, Wouter Korver, Shweta Singh, Mary Haak-Frendscho, Vinay Bhaskar, Anti-cd38 antibodies ,(2011)
Claude Geoffrey Davis, Nobuaki Hori, Aya Jakobovits, Krisztina M. Zsebo, Production of a multimeric protein by cell fusion method ,(1997)
Peter U Park, Michele F Mayo, Pascale Lejeune, Jutta Deckert, Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib ,(2011)
Daryl Tan, Sathish Krishnan, Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies Blood and Lymphatic Cancer: Targets and Therapy. ,vol. 3, pp. 19- 24 ,(2013) , 10.2147/BLCTT.S29567